Two Sigma Advisers’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43K | Buy |
|
|||||
|
2025
Q1 | $41.9K | Hold |
|
|||||
|
2024
Q4 | $39.2K | Sell |
|
|||||
|
2024
Q3 | $50.8K | Sell |
|
|||||
|
2024
Q2 | $52.8K | Sell |
|
|||||
|
2024
Q1 | $45.4K | Sell |
|
|||||
|
2023
Q4 | $77.5K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $31.5K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $175K | Sell |
|
|||||
|
2022
Q1 | $704K | Sell |
|
|||||
|
2021
Q4 | $1.34M | Buy |
|
|||||
|
2021
Q3 | $497K | Sell |
|
|||||
|
2021
Q2 | $681K | Sell |
|
|||||
|
2021
Q1 | $1.4M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $75K | Sell |
|
|||||
|
2020
Q2 | $303K | Buy |
|
|||||
|
2020
Q1 | $135K | Buy |
|
|||||
|
2019
Q4 | $225K | Buy |
|
|||||
|
2019
Q3 | $121K | Sell |
|
|||||
|
2019
Q2 | $180K | Buy |
|
|||||
|
2019
Q1 | $127K | Buy |
|
|||||
|
2018
Q4 | $63K | Buy |
|
|||||
|
2018
Q3 | $133K | Buy |
|